BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31077558)

  • 1. Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.
    Salem DA; Scott D; McCoy CS; Liewehr DJ; Venzon DJ; Arons E; Kreitman RJ; Stetler-Stevenson M; Yuan CM
    Cytometry B Clin Cytom; 2019 Jul; 96(4):275-282. PubMed ID: 31077558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the muscle-associated gene MYF6 in hairy cell leukemia.
    Arons E; Zhou H; Sokolsky M; Gorelik D; Potocka K; Davies S; Fykes E; Still K; Edelman DC; Wang Y; Meltzer PS; Raffeld M; Wiestner A; Xi L; Wang HW; Stetler-Stevenson M; Yuan C; Kreitman RJ
    PLoS One; 2020; 15(2):e0227586. PubMed ID: 32040482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
    Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
    Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
    Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
    Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders.
    Pillai V; Pozdnyakova O; Charest K; Li B; Shahsafaei A; Dorfman DM
    Am J Clin Pathol; 2013 Oct; 140(4):536-43. PubMed ID: 24045551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristic CD103 and CD123 expression pattern defines hairy cell leukemia: usefulness of CD123 and CD103 in the diagnosis of mature B-cell lymphoproliferative disorders.
    Venkataraman G; Aguhar C; Kreitman RJ; Yuan CM; Stetler-Stevenson M
    Am J Clin Pathol; 2011 Oct; 136(4):625-30. PubMed ID: 21917686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical presentation of hairy cell leukemia: Significance of CD200 on flow cytometry.
    Rahman K; Kumari S; Singh MK; Gupta R; Yadav G; Kumari N; Nityan S
    J Cancer Res Ther; 2018; 14(5):1130-1134. PubMed ID: 30197362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
    Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
    Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which Markers Should the used for Diagnostic Chronic Lymphocytic Leukemia Immunophenotyping Scoring System by Flow Cytometry?
    Falay M; Serdar MA; Dalgali H; Uçar MA; Dagdaş S; Özet G
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
    Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
    Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
    Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunophenotypic analysis of CD103+ B-lymphoproliferative disorders: hairy cell leukemia and its mimics.
    Dong HY; Weisberger J; Liu Z; Tugulea S
    Am J Clin Pathol; 2009 Apr; 131(4):586-95. PubMed ID: 19289595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological spectrum of hairy-cell leukemia: A single-center study with brief review of Indian literature.
    Gupta R; Yadav S; Mittal N; Rahman K; Sharma A; Gupta A; Nityan S
    J Cancer Res Ther; 2020; 16(1):120-126. PubMed ID: 32362621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow Cytometric Patterns of CD200 and CD1d Expression Distinguish CD10-Negative, CD5-Negative Mature B-Cell Lymphoproliferative Disorders.
    Mason EF; Pozdnyakova O; Li B; Dudley G; Dorfman DM
    Am J Clin Pathol; 2017 Jul; 148(1):33-41. PubMed ID: 28575142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of CD39, CD43, CD81, and CD95 expression for differentiating B cell lymphoma by flow cytometry.
    Cardoso CC; Auat M; Santos-Pirath IM; Rudolf-Oliveira RCM; da Silva JP; Lange BG; Siegel D; de Moraes ACR; Del Moral JAG; Santos-Silva MC
    Cytometry B Clin Cytom; 2018 May; 94(3):451-458. PubMed ID: 28509416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
    Wierda WG; Byrd JC; Abramson JS; Bhat S; Bociek G; Brander D; Brown J; Chanan-Khan A; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lancet J; Ma S; Malek S; Mosse C; Shadman M; Siddiqi T; Stephens D; Wagner N; Zelenetz AD; Dwyer MA; Sundar H
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1414-1427. PubMed ID: 29118233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF V600E mutation detection in hairy cell leukemia-utility of archival DNA from bone marrow aspirate/imprint smear and amplification refractory mutation system.
    Naseem S; Gupta O; Binota J; Varma N; Varma S; Malhotra P
    Mol Biol Rep; 2020 Jun; 47(6):4365-4372. PubMed ID: 32458259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation.
    Xi L; Arons E; Navarro W; Calvo KR; Stetler-Stevenson M; Raffeld M; Kreitman RJ
    Blood; 2012 Apr; 119(14):3330-2. PubMed ID: 22210875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive immunophenotypic marker analysis of hairy cell leukemia in paraffin-embedded bone marrow trephine biopsies--a tissue microarray study.
    Tóth-Lipták J; Piukovics K; Borbényi Z; Demeter J; Bagdi E; Krenács L
    Pathol Oncol Res; 2015 Jan; 21(1):203-11. PubMed ID: 24903677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.